Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis | Cochrane

Myelofibrosis is a disorder of the bone marrow in which the bone marrow is replaced by fibrous tissue. The symptoms depend on the degree of anemia and enlargement of the spleen. This condition has a poor prognosis and generally its treatment is palliative.